SCHEMBL1130239

SCHEMBL1130239

C[S+](C)c1ccc(O)c2ccccc12.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.51

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 2/20 0.51
KAT2B Q92831 2/20 0.51
KAT8 Q9H7Z6 2/20 0.51
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
GAA P10253 3/20 0.48
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
HKDC1 Q2TB90 1/20 0.44
COMT P21964 1/20 0.42
LDHA P00338 1/20 0.41
MAP1LC3B Q9GZQ8 1/20 0.41
PKM P14618 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PSD A5PKW4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RRM1 P23921 1/20 0.39
G6PD P11413 1/20 0.39
S100A4 P26447 1/20 0.38
KEAP1 Q14145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759525 0.85 KMT2A (0.39) EP300KAT2BKAT8MEN1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL31168271 0.79 LDHA (0.44) EP300KAT2BKAT8MEN1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL36124 0.79 LDHA (0.44) EP300KAT2BKAT8MEN1KMT2A
SCHEMBL29420748 0.79 IDO1 (0.59) EP300KAT2BKAT8LDHATDP1
SCHEMBL132348 0.79 IDO1 (0.59) EP300KAT2BKAT8LDHATDP1
SCHEMBL3812585 0.78 HCRTR1 (0.47) MEN1KMT2AGAAESR1ESR2
Hydrochloric Acid SCHEMBL4410534 0.78 IDO1 (0.56) EP300KAT2BKAT8LDHATDP1
SCHEMBL562392 0.75 GAA (0.41) MEN1KMT2AGAATDP1L3MBTL1
SCHEMBL3871600 0.74 KMT2A (0.58) MEN1KMT2AGAAESR1ESR2
SCHEMBL1130786 0.74 IDO1 (0.43) EP300KAT2BKAT8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1323742-B1 Radiation sensitive refractive index changing composition and refractive index changing method JSR CORP (JP) 2011-02-16 EP disclosed
US-7842441-B2 Norbornene polymer for photoresist and photoresist composition comprising the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-11-30 US disclosed
US-20090221845-A1 FLUORINATED COMPOUND, AND FLUOROPOLYMER, PROCESS FOR ITS PRODUCTION AND RESIST COMPOSITION CONTAINING IT ASAHI GLASS COMPANY, LIMITED (JP) 2009-09-03 US disclosed
US-7550545-B2 Fluorinated compound, and fluoropolymer, process for its production and resist composition containing it ASAHI GLASS COMPANY, LIMITED (JP) 2009-06-23 US disclosed
US-20090075207-A1 NORBORNENE POLYMER FOR PHOTORESIST AND PHOTORESIST COMPOSITION COMPRISING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2009-03-19 US disclosed
US-7498393-B2 Fluorinated compound, fluoropolymer, resist composition, and composition for resist protective film ASAHI GLASS COMPANY, LIMITED (JP) 2009-03-03 US disclosed
US-20080145783-A1 Photosensitive Resin Composition and Organic Insulating Film Produced Using the Same CHEIL INDUSTRIES INC. (KR) 2008-06-19 US disclosed
US-7320854-B2 Mixture of oxide particles, polymerizable compound,radiation sensitive decomposer and releasing agent JSR CORPORATION (JP) 2008-01-22 US disclosed
EP-1365290-B1 RESIST COMPOSITION ASAHI GLASS CO LTD (JP) 2007-11-21 EP disclosed
US-20070207409-A1 FLUORINATED COMPOUND, AND FLUOROPOLYMER, PROCESS FOR ITS PRODUCTION AND RESIST COMPOSITION CONTAINING IT ASAHI GLASS COMPANY, LIMITED (JP) 2007-09-06 US disclosed
EP-1375597-A1 RADIATION-SENSITIVE COMPOSITION CHANGING IN REFRACTIVE INDEX AND UTILIZATION THEREOF JSR Corporation (JP) 2004-01-02 EP disclosed
EP-1369459-A1 RADIATION-SENSITIVE COMPOSITION CAPABLE OF HAVING REFRACTIVE INDEX DISTRIBUTION JSR Corporation (JP) 2003-12-10 EP disclosed
EP-1365290-A1 RESIST COMPOSITION ASAHI GLASS COMPANY LTD. (JP) 2003-11-26 EP disclosed
EP-1350814-A1 RADIATION-SENSITIVE COMPOSITION CHANGING IN REFRACTIVE INDEX AND METHOD OF CHANGING REFRACTIVE INDEX JSR Corporation (JP) 2003-10-08 EP disclosed
US-20030187119-A1 Radiation-sensitive composition capable of having refractive index distribution JSR CORPORATION (JP) 2003-10-02 US disclosed
US-20030171468-A1 Radiation-sensitive composition changing in refractive index and utilization thereof JSR CORPORATION (JP) 2003-09-11 US disclosed
EP-1343047-A2 Resist composition ASAHI GLASS COMPANY LTD. (JP) 2003-09-10 EP disclosed
US-20030139486-A1 Radiation sensitive refractive index changing composition and refractive index changing method JSR CORPORATION (JP) 2003-07-24 US disclosed
EP-1323742-A2 Radiation sensitive refractive index changing composition and refractive index changing method JSR Corporation (JP) 2003-07-02 EP disclosed
EP-0789278-A2 Radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1997-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221845-A1 FLUORINATED COMPOUND, AND FLUOROPOLYMER, PROCESS FOR ITS PRODUCTION AND RESIST COMPOSITION CONTAINING IT AFF4, AFF1, Q6ZSR9 EP300 2032/4885KAT2B 1280/4885KAT8 1369/4885
US-20070207409-A1 FLUORINATED COMPOUND, AND FLUOROPOLYMER, PROCESS FOR ITS PRODUCTION AND RESIST COMPOSITION CONTAINING IT AFF4, AFF1, Q6ZSR9 EP300 2032/4885KAT2B 1280/4885KAT8 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.